Overview
Ulcerative stomatitis, commonly referred to as mucositis, is a significant toxicity of cancer therapy that can lead to numerous systemic sequelae 1. It is characterized by inflammation and ulceration of the mucous membranes of the oral cavity 1.
Diagnosis
Grading of mucositis is performed using established criteria 1.Management
Management strategies are evidence-based and setting-specific for patients undergoing cancer therapy 1.
Guidelines cover various interventions for mucositis 1.Key Recommendations
Guidelines are developed based on the level of evidence, with possible determinations of recommendation, suggestion, or no guideline possible 1.
The MASCC/ISOO Clinical Practice Guidelines provide a clinical setting-specific, evidence-based tool for managing mucositis in cancer patients 1.
Thirteen new guidelines were developed for or against the use of various interventions in specific treatment settings 1.
Eleven previous guidelines were confirmed after a review of new evidence 1.
Thirteen previously established guidelines were carried over due to a lack of new evidence 1.References
1 Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM et al.. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 2020. link